Roth Capital Downgrades Uroplasty To Neutral

Roth Capital has downgraded Uroplasty UPI from Buy to Neutral.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: DowngradesAnalyst RatingsHealth CareHealth Care SuppliesRoth Capital
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!